HomepageBIOG-B • STO
add
BioGaia AB
Vorige slotkoers
kr 94,90
Dag-range
kr 94,15 - kr 96,20
Jaar-range
kr 93,50 - kr 139,70
Beurswaarde
9,30Â mld. SEK
Gem. volume
164,76K
Koers/winst
-
Dividendrendement
-
Primaire beurs
STO
Marktnieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
(SEK) | jun 2025info | Wijziging j-o-j |
---|---|---|
Opbrengst | 404,69Â mln. | 5,36% |
Bedrijfskosten | 180,74Â mln. | 26,52% |
Netto inkomsten | 87,91Â mln. | -20,81% |
Netto winstmarge | 21,72 | -24,84% |
Winst per aandeel | 0,87 | — |
EBITDA | 119,34Â mln. | -19,00% |
Effectief belastingtarief | 20,38% | — |
Balans
Totale activa
Totale passiva
(SEK) | jun 2025info | Wijziging j-o-j |
---|---|---|
Contanten en kortetermijnbeleggingen | 622,34Â mln. | -38,24% |
Totale activa | 1,43Â mld. | -24,64% |
Totale passiva | 277,75Â mln. | -14,64% |
Totaal aandelenvermogen | 1,15 mld. | — |
Uitstaande aandelen | 101,16 mln. | — |
Koers-boekwaardeverhouding | 8,32 | — |
Rendement op activa | 16,33% | — |
Rendement op kapitaal | 19,28% | — |
Kasstroom
Nettomutatie in liquide middelen
(SEK) | jun 2025info | Wijziging j-o-j |
---|---|---|
Netto inkomsten | 87,91Â mln. | -20,81% |
Operationele kasstroom | 77,17Â mln. | -35,22% |
Kasstroom uit beleggingen | -1,17Â mln. | 47,93% |
Kasstroom uit financiering | -699,76Â mln. | -0,09% |
Nettomutatie in liquide middelen | -626,95Â mln. | -7,42% |
Vrije kasstroom | 72,43Â mln. | -27,77% |
Over
BioGaia is a Swedish biotechnology company that develops, markets and sells a range of probiotic products. It has patented the use of several Lactobacillus reuteri strains and offers gut and immune health products containing L. reuteri Protectis. Their oral health products contain L. reuteri Prodentis, a blend of the L. reuteri strains DSM 17938 and ATCC PTA 5289. Products containing L. reuteri have been proven to be both effective and safe in several applications: infant colic, diarrhea prevention and mitigation in children, eradication of H. pylori infection and reduction of side effects from standard H. pylori treatment, amelioration of gingivitis, and general illness prevention in children and adults. BioGaia was ranked 9th in the Top 30 Global Probiotic Food Ingredient Companies list by FoodTalks in 2021. The BioGaia -B share is listed on the NASDAQ OMX Nordic Exchange. Wikipedia
Opgericht
1990
Website
Werknemers
230